Refine by
Clinical Value Articles & Analysis
43 news found
Following regulatory approval, Advanced Instruments, a wholly-owned subsidiary within Patricia Industries, has now completed its acquisition of Nova Biomedical, a global provider of analytical instruments and consumables for the biopharmaceutical and clinical markets. The enterprise value amounts to USD 2.2bn. Patricia Industries has contributed USD 1.6bn in ...
Carolina Reduzzi, an Assistant Professor of Cancer Biology Research in Medicine and Director of the Liquid Biopsy Platform of the Englander Institute for Precision Medicine (EIPM) at Weill Cornell Medicine. “The development and clinical validation of a potentially more sensitive and informative method for detecting minimal residual disease in patients with EBC may help ...
Therefore, flow cytometry is widely used in clinical diagnosis and medical research, such as tumor-associated diseases, autoimmune diseases, cardiovascular diseases, inflammatory infections and infectious diseases, providing higher clinical value for differential diagnosis, treatment monitoring and condition assessment. ...
Advanced Instruments, a leading provider of analytical instruments and services for clinical and biopharmaceutical laboratories, is proud to announce the expansion of its Artel portfolio’s direct presence in Austria, France, Germany, and Switzerland. ...
” Bjöern von Siemens, co-founder and CFO: “2023 has been a particularly successful chapter in our decade-long journey, marked by growing our GAAP revenue by 100 percent, showing clear financial and clinical ROI on hospital level and forging impactful value partnerships with our clients. ...
Compared with other drug conjugates, PDCs have a wider industrial base and clinical value. Our conjugation platform and experience allow us to further forge partnerships with customers who depend on our capabilities for the development and commercial production of high-quality peptide drug conjugates.” ...
“Combining our knowledge and experience with Bayer will enable us to provide solutions to deliver ongoing clinical value to radiologists and their referrers.” About AI in Radiology The overall global medical imaging AI field had sales worth more than USD 400 million in 2021. ...
ByBayer AG
“Combining our knowledge and experience as one of the leading platform providers in the industry with Bayer’s advanced radiology portfolio will enable us to provide solutions to deliver ongoing clinical value to radiologists and their teams.” The overall global medical imaging AI field with sales of more than USD 400 million in 2021 is expected ...
ByBayer AG
Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces a new study in the Journal of Cardiovascular Translational Research that examined pressure-volume profiles in heart failure patients using Daxor’s BVA-100 blood test to measure intravascular volume overload compared to a commercially available implantable pulmonary artery diastolic ...
Ezisurg Medical’s staplers have been approved by the Saudi Food and Drug Authority recently. This is the latest achievement made in Ezisurg Medical’s international sector, soon after finishing CE and FDA certification or ...
The studies demonstrate health economic and clinical value of the Zio® AT and XT product lines across a range of diseases and clinical settings. “The presented studies have important clinical implications,” said Dr. Mintu Turakhia, iRhythm’s chief medical officer and chief scientific officer. “First, ...
The CPU highlights some WATS3D clinical evidence, which demonstrated an increased yield for dysplasia detection, and that pathologic interpretation of these specimens has been shown to have significantly higher interobserver agreement, with a kappa of 0.86. “CDx is committed to providing physicians with an AI-based diagnostic solution that empowers them to prevent ...
Relocation assistance may be available. Values: INTEGRITY: We honor each of our commitments – including those that outsiders would consider trivial – with strict adherence to the highest ethical standards. ...
The LIAISON MeMed BV test expands DiaSorin’s market leading menu of fully-automated, chemiluminescent immunoassay panels for the diagnosis of infectious diseases and highlights the Group’s efforts to develop innovative, fully automated diagnostic solutions, with the aim of optimizing laboratory efficiency and clinical decision-making. The LIAISON MeMed BV U.S. Food ...
ByMeMed
In July 2021, Professor Yundai Chen of the Chinese People's Liberation Army General Hospital led a team to perform the first clinical IVL procedure in China to treat a patient with severely calcified coronary artery lesions. ...
Morten Isaksen moves up to the Board and will also continue as Chief Innovation Officer with a focus on longer term and higher-value clinical applications for the company’s Precision Microbiome Profiling (PMP™) technology. ...
ByBio-Me
“Gaboxadol shows encouraging activity and a good safety profile in a range of conditions. We are keen to see its clinical value unlocked,” said Jeremy Levin, D.Phil, MB BChir, Chairman and Chief Executive Officer of Ovid Therapeutics. ...
(Abstract 56) “These studies further demonstrate the significant clinical value that our blood tests offer in detecting and monitoring cancer, which can help physicians make informed treatment decisions in patients with early- or late-stage gastrointestinal cancer without the need for an invasive tissue biopsy,” said Helmy Eltoukhy, Guardant Health ...
(NASDAQ: EXAS), a global leader in cancer diagnostics, today announced the presentation of new data at the 2021 San Antonio Breast Cancer Symposium (SABCS) supporting the clinical value of the Oncotype DX Breast Recurrence Score test. New analyses presented at the meeting include an oral presentation of updated data from the RxPONDER study led by the independent ...
GI Innovation licensed out main pipeline, immuno-oncology GI-101 (Simcere China) and allergic disease treatment GI-301 (Yuhan Pharm.) in non-clinical stage value of 2.3 trillion won and currently each pipeline is progressing global clinical 1/2 phase and domestic clinical 1 phase. ...